first antibody
1135 Results
Advanced Search
Showing
Narrow Your Results Use the filters below to refine your search
By Application
By Brand
By Industry
-
-
Plates | Life Science Research | Merck
Learn about the key factors in developing a successful ELISpot assay: from plate chemistry, to layout of controls, to plate handling practices. -
Event | European Advance Biotech Grant Program | Merck
We invite you to join us for the European Advance Biotech Grant Program as we recognize and celebrate the winners of the Advance biotech Grant program -
IP-Western | Life Science Research | Merck
The possible causes and potential remedies for challenges encountered in the immunoprecipitation-Western blot technique, which consists of cell lysis, formation of the antibody-antigen (immune) complex, precipitation of the immune complexes, and analysis by Western blotting. -
Protein Phosphorylation | Life Science Research | Merck
Protein phosphorylation systems are composed of at least three components: (a) phosphoproteins (b) kinases and (c) phosphatases, that dephosphorylate the phosphoproteins, thereby restoring the system to its basal stage. -
Cell Culture Media and Reagents | Life Science Research | Merck
In general, We are deeply committed to providing novel cell culture systems and characterization tools for stem cell research and primary cell culture. -
Western Blotting Applications Notes | Life Science Research | Merck
Discover updated application notes for Western blotting topics and find useful insights for antibody reuse, triple well blotting, and immunodetection applications. -
Inhibitor Libraries and Pathway Panels | Life Science Research | Merck
This introduction to our inhibitors, biochemicals, antibodies, proteins, and kits includes information and tips that can fast-track your research. -
Press Release: Merck Opens China's First BioReliance® End-to-End Biodevelopment Center in Shanghai
Merck today announced the opening of its first BioReliance® End-to-End Biodevelopment Center in the Asia Pacific (APAC) region. -
Press Release: Merck to Provide Provantage® End-to-End Development and Manufacturing Services to Y-mAbs for Lead Antibody Compound
Merck will provide its Provantage® End-to-End development and manufacturing services to Y-mAbs Therapeutics, Inc. in support of Y-mAbs' monoclonal antibody in late stage clinical development